Nitric oxide and its derivatives in the cancer battlefield: Kamm et al. (2019) Nitric Oxide: S1089-8603 (19) 30119-3.

September 16, 2019 /

Elevated levels of reactive nitrogen species, alteration in redox balance and deregulated redox signaling are common hallmarks of cancer progression and chemoresistance. However, depending on the cellular context, distinct reactive nitrogen species are also hypothesized to mediate cytotoxic activity and are thus used in anticancer therapies. We present here the dual face of nitric oxide and its derivatives in cancer biology. Main derivatives of nitric oxide, such as nitrogen dioxide and peroxynitrite cause cell death by inducing protein and lipid peroxidation and/or DNA damage. Moreover, they control the activity of important protein players within the pro- and anti-apoptotic signaling pathways. Thus, the control of intracellular reactive nitrogen species may become a sophisticated tool in anticancer strategies. 

For reference, see Nitric oxide and its derivatives in the cancer battlefield.  Kamm, A., Przychodzen, P., Kuban-Jankowska, A., Jacewicz, D., Dabrowska, A.M., Nussberger, S., Wozniak, M. &  Gorska-Ponikowska, M. Nitric Oxide: S1089-8603 (19) 30119-3.  (2019)

Contact

 

Biophysics Group, Institute of Biomaterials and biomolecular Systems, University of Stuttgart

Pfaffenwaldring 57 , D-70569 Stuttgart, Germany

To the top of the page